ACIR BioSciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

ACIR BioSciences General Information

Description

Developer of immunotherapies intended to treat cancer and other diseases. The company develops long-acting cytokines, human Interleukin-10, including AM0010 and any other PEGylated forms as immunotherapies, thereby enabling clinicians to treat heart diseases, cancer, tumors, and other cardiovascular diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 575 Chesapeake Drive
  • Redwood City, CA 94063
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 575 Chesapeake Drive
  • Redwood City, CA 94063
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACIR BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Oct-2015 Completed Startup
1. Early Stage VC Completed Startup
To view ACIR BioSciences’s complete valuation and funding history, request access »

ACIR BioSciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
ND Capital Venture Capital Minority
To view ACIR BioSciences’s complete investors history, request access »

ACIR BioSciences FAQs

  • When was ACIR BioSciences founded?

    ACIR BioSciences was founded in 2014.

  • Where is ACIR BioSciences headquartered?

    ACIR BioSciences is headquartered in Redwood City, CA.

  • What industry is ACIR BioSciences in?

    ACIR BioSciences’s primary industry is Drug Discovery.

  • Is ACIR BioSciences a private or public company?

    ACIR BioSciences is a Private company.

  • What is ACIR BioSciences’s current revenue?

    The current revenue for ACIR BioSciences is .

  • How much funding has ACIR BioSciences raised over time?

    ACIR BioSciences has raised $10M.

  • Who are ACIR BioSciences’s investors?

    ND Capital has invested in ACIR BioSciences.

  • When was ACIR BioSciences acquired?

    ACIR BioSciences was acquired on 01-Oct-2015.

  • Who acquired ACIR BioSciences?

    ACIR BioSciences was acquired by ARMO BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process